Foralumab Nasal

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)NCT06868628TLSAPhase 2Recruiting2027-04-01Estimated
The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal ForalumabNCT07688239TLSAPhase 2Enrolling by invitation2027-07Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.